RMH Sciences aims to commercialize newly discovered antibiotics.

RMH Sciences aims to commercialize newly discovered antibiotics by Dr. Harvey Rubin, University of Pennsylvania Professor of Medicine. One of RMH’s most promising ventures focuses on creating antibiotics to combat hospital acquired bacterial pathogens, a largely unmet need in the current marketplace.

Industry: Health
Status: Alumni

Contact Information

http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=209576114

Dr. Harvey Rubin

Co-Founder

Glenn Mattes

President & CEO

George Hobbs

VP